INTRODUCTION
a palpable firm mass on the medial volar aspect of the left forearm measuring about 7 cm × 5 cm × 3 cm with surgical scar with few dilated veins over the swelling with no bruit. There was no distal neurovascular deficit. Hand functions were normal. Magnetic resonance imaging of the upper forearm showed the mass with high vascularity, involving mainly the muscular plane. The biopsy report showed the possibility of glomangioma or epithelioid haemangioendothelioma, which was a benign condition, and so excision biopsy was done.
A lazy 'S' incision was made over the swelling. Highly vascular mass was found encapsulated within the flexor digitorum superficialis (FDS) muscle at the common flexor origin [ Figure 2a and b]. The ulnar nerve was found closely adhered to the capsule of the mass and was dissected after dividing its muscular branches [ Figure 3 ]. Mass was excised along with part of FDS muscle up to the musculotendinous junction; the remaining tendinous part was attached to flexor digitorum profundus muscle with adequate tension.
Histopathology examination showed nests of large polygonal cells with abundant eosinophilic cytoplasm having pseudoalveolar pattern [ Figure 4a and b], separated by delicate vascular structures. All the findings confirmed ASPS.
The patient was screened for metastasis post-operatively. Computed tomography (CT) chest showed multiple coin-like opacities in both the lung fields, more in lower lobes [ Figure 5 ]. CT brain, CT abdomen and whole-body skeletal survey were normal.
After discussion with oncology department (radiation oncology, medical oncology and surgical oncology), we decided to give cycles of chemotherapy and radiotherapy.
The patient received 6 cycles of chemotherapy with adriamycin, cyclophosphamide and vincristine as suggested by the oncologist. The patient was closely followed for 11 months. There was no locoregional recurrence or metastasis elsewhere. Full range of movements in the hand and elbow was possible.
After 11 months, the patient had good functional improvement [ Figure 6a and b], due to financial constraints, PET scan and other investigations were not done on subsequent follow-up. 
DISCUSSION
ASPS is one of the rarest forms of soft-tissue sarcoma. This tumour commonly occurs in females, with a male: female ratio of 1:2 and the mean age 22-25. Most common site of origin is lower extremity, [7] then the trunk and the upper limbs. ASPS represents <1% of all soft-tissue sarcomas, and they form one-third of all metastatic soft-tissue sarcomas (33%). [8] The genetic theory for ASPS [1] is thought to be its origin in chromosomal rearrangement at t (X:17) (p11:Q25), resulting in the ASPL-TFE3 fusion gene. [9] Since women have two X chromosomes, they are more prone for ASPS.
This tumour is slow-growing in nature, but the metastases are more common to the lung followed by bone and brain. Lymph node metastasis is rare. [5] Prognosis of ASPS depends on patient's age, tumour size and the presence of metastasis at the time of diagnosis. Metastases are detected in 20%-25% of the patients at the time of diagnosis.
ASPS are more vascular in nature, because of these prominent vascular structure, the mass shows high-intensity signals in T1-and T2-weighed images [3] and resembles those of haemangioma, but histologically, it shows typical features of ASPS.
Histologically, the tumour has peculiar, orderly arranged epithelioid-appearing tumour cells separated by delicate fibrovascular septae. ASPS can be easily differentiated from its histopathological mimics by demonstrating cytological uniformity, lack of nuclear atypia and paucity of mitotic figures in ASPS. [6] Treatment For primary tumour, extensive resection of the mass (R0 resection: Complete resection with no microscopic residual tumour) and adjuvant regional radiotherapy is considered as the most effective treatment of ASPS. The management algorithm for soft-tissue sarcoma [Flow chart 1] is shown below. [10] The local recurrence rate reportedly ranges from 10% to 30% after the removal of the mass and an adjunctive radiation treatment could be beneficial to prevent a relapse. Combination of surgery with radiotherapy and chemotherapy may prolong the mean survival time. There are reports regarding excision of pulmonary metastases providing a good prognosis along with radiotherapy or chemotherapy. In the literature, 5-year overall survival was reported as 83%. The presence of lung metastases is not a contraindication for surgery in patients with ASPS. The reason for favourable prognosis with this tumour can be explained by the slow-growing and indolent nature of this disease.
CONCLUSION
ASPS are one of the rarest soft-tissue tumours, which rarely involve upper extremity. To the best of our knowledge, very few cases of ASPS has been reported from India. Characteristic histological features would facilitate an early diagnosis. Long-term follow-up is needed to find out the recurrence of a tumour or metastasis. Because of its rarity of occurrence in the upper extremity, this case has been reported.
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